A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

Peters, S; Danson, S; Hasan, B; Dafni, U; Reinmuth, N; Majem, M; Tournoy, KG; Mark, MT; Pless, M; Cobo, M; Rodriguez-Abreu, D; Falchero, L; Moran, T; Granados, ALO; Monnet, I; Mohorcic, K; Sureda, BM; Betticher, D; Demedts, I; Macias, JA; Cuffe, S; Luciani, A;...

A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER

Goldman, JW; Mazieres, J; Barlesi, F; Dragnev, KH; Koczywas, M; Goskel, T; Cortot, AB; Girard, N; Wesseler, C; Bischoff, H; Nadal, E; Park, K; Lu, S; Taus, A; Cobo, M; Estrem, ST; Wijayawardana, SR; Turner, K; Oakley, GJ; Hurt, KC; Chiang, AY; Hossain, AM; John, WJ;...